(Q39242999)

10 September 2017

title

p53 acetylation enhances Taxol-induced apoptosis in human cancer cells (English)

1 reference

10 September 2017

0 references

Jae Hyeong Kim

1

1 reference

10 September 2017

Eun-Kyung Yoon

2

1 reference

10 September 2017

Hye-Jin Chung

3

1 reference

10 September 2017

Seong-Yeol Park

4

1 reference

10 September 2017

Kyeong-Man Hong

5

1 reference

10 September 2017

Chang-Hun Lee

6

1 reference

10 September 2017

Yeon-Su Lee

7

1 reference

10 September 2017

Kyungho Choi

8

1 reference

10 September 2017

Young Yang

9

1 reference

10 September 2017

Kyungtae Kim

10

1 reference

10 September 2017

In-Hoo Kim

11

1 reference

10 September 2017

publication date

1 January 2013

1 reference

10 September 2017

1 reference

10 September 2017

volume

18

1 reference

10 September 2017

issue

1

1 reference

10 September 2017

page(s)

110-120

1 reference

Cell cycle G2/M arrest and activation of cyclin-dependent kinases associated with low-dose paclitaxel-induced sub-G1 apoptosis.

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Spindle poisons and cell fate: a tale of two pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

On the road to cancer: aneuploidy and the mitotic checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Destruction's our delight: controlling apoptosis during mitotic arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Molecular effects of paclitaxel: myths and reality (a critical review).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

p53-independent apoptosis induced by paclitaxel through an indirect mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Enhanced microtubule-dependent trafficking and p53 nuclear accumulation by suppression of microtubule dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

21 January 2018

Modes of p53 regulation

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Acetylation of the DNA binding domain regulates transcription-independent apoptosis by p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

p53 acetylation is crucial for its transcription-independent proapoptotic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Acetylation is indispensable for p53 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Increased p53 phosphorylation after microtubule disruption is mediated in a microtubule inhibitor- and cell-specific manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Cisplatinum and taxol induce different patterns of p53 phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Cancer-specific functions of SIRT1 enable human epithelial cancer cell growth and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Requirement for p53 and p21 to sustain G2 arrest after DNA damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

The critical role of the class III histone deacetylase SIRT1 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

A synthetic inhibitor of histone deacetylase, MS-27-275, with marked in vivo antitumor activity against human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Modulation of p53 function by SET8-mediated methylation at lysine 382

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

C-terminal ubiquitination of p53 contributes to nuclear export

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

A phase I study of the safety and pharmacokinetics of the histone deacetylase inhibitor belinostat administered in combination with carboplatin and/or paclitaxel in patients with solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

Synergistic antitumor effects of novel HDAC inhibitors and paclitaxel in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

p53 activity and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-012-0772-8

10.1007/S10495-012-0772-8

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference